美国血液学会 2020 年年会亮点
Highlights from the American society of hematology conference 2020.
机构信息
Division of Hematology and Oncology, University of Cincinnati, Cincinnati, OH, 45267, USA.
出版信息
J Thromb Thrombolysis. 2021 Jul;52(1):354-362. doi: 10.1007/s11239-021-02449-9. Epub 2021 Apr 26.
Abstract
American Society of Hematology conducts an annual meeting, where investigators from around the globe presented ground-breaking research in the fields of malignant and non-malignant hematology. We provide a summary of non-malignant hematology abstracts from the 2020 meeting. Topics included range from those related to thrombosis, including thrombotic complications of COVID-19, bleeding and novel therapies such as gene therapies. Readers are encouraged to access meeting materials for a more detailed coverage of the event.
摘要
美国血液学会每年都会举办一次会议，来自全球各地的研究人员在恶性血液病和非恶性血液病领域展示了开创性的研究成果。我们对 2020 年会议的非恶性血液病摘要进行了总结。其中包括与血栓形成相关的主题，如 COVID-19 的血栓并发症、出血和新型治疗方法，如基因治疗。鼓励读者查阅会议资料，以获取更详细的会议报道。
相似文献
1
Highlights from the American society of hematology conference 2020.美国血液学会 2020 年年会亮点
J Thromb Thrombolysis. 2021 Jul;52(1):354-362. doi: 10.1007/s11239-021-02449-9. Epub 2021 Apr 26.
2
Highlights in gene therapy and alternative therapies in nonmalignant hematology from the 2016 American Society of Hematology meeting.2016年美国血液学会会议上非恶性血液学领域基因治疗及替代疗法亮点
Clin Adv Hematol Oncol. 2017 Feb;15(2):113-116.
3
58th American Society of Hematology Annual Meeting.第58届美国血液学会年会
Lancet Haematol. 2017 Jan;4(1):e13-e14. doi: 10.1016/S2352-3026(16)30197-1.
4
Major bleeding complications in critically ill patients with COVID-19 pneumonia.新冠肺炎重症肺炎患者的主要出血并发症。
J Thromb Thrombolysis. 2021 Jul;52(1):18-21. doi: 10.1007/s11239-021-02403-9. Epub 2021 Mar 1.
5
Hypoxia-An overlooked trigger for thrombosis in COVID-19 and other critically ill patients.缺氧——新冠病毒感染及其他重症患者中被忽视的血栓形成诱因
J Thromb Haemost. 2020 Nov;18(11):3109-3110. doi: 10.1111/jth.15029.
6
Highlights in nonmalignant hematology from the 2019 American Society of Hematology meeting.2019年美国血液学会会议非恶性血液学亮点
Clin Adv Hematol Oncol. 2020 Feb;18(2):86-88.
7
Highlights in COVID-19 from the 62nd American Society of Hematology Annual Meeting.第62届美国血液学会年会中关于新型冠状病毒肺炎的亮点
Clin Adv Hematol Oncol. 2021 Mar;19(3):140-143.
8
Abstracts of papers presented at the twentieth annual general meeting of the British Society for Haematology: joint meeting with Nederlandse Vereniging voor Hematologie, Aviemore, April 1979.英国血液学学会第二十届年会论文摘要：与荷兰血液学协会联合会议，1979年4月于阿维莫尔
Br J Haematol. 1979 Nov;43(3):485-506. doi: 10.1111/j.1365-2141.1979.tb03780.x.
9
10
A review on how to do hematology consults during COVID-19 pandemic.关于如何在 COVID-19 大流行期间进行血液学咨询的综述。
Blood Rev. 2021 May;47:100777. doi: 10.1016/j.blre.2020.100777. Epub 2020 Nov 8.
本文引用的文献
1
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.COVID-19、免疫血栓形成和静脉血栓栓塞症：生物学机制。
Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6.
2
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.CRISPR-Cas9 基因编辑治疗镰状细胞病和 β-地中海贫血。
N Engl J Med. 2021 Jan 21;384(3):252-260. doi: 10.1056/NEJMoa2031054. Epub 2020 Dec 5.
3
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.2019冠状病毒病的血栓栓塞风险很高，且与更高的死亡风险相关：一项系统评价和荟萃分析。
EClinicalMedicine. 2020 Dec;29:100639. doi: 10.1016/j.eclinm.2020.100639. Epub 2020 Nov 20.
4
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.2019冠状病毒病患者发生静脉血栓栓塞的风险：一项系统评价和荟萃分析
Res Pract Thromb Haemost. 2020 Oct 13;4(7):1178-1191. doi: 10.1002/rth2.12439. eCollection 2020 Oct.
5
Postdischarge thrombosis and hemorrhage in patients with COVID-19.COVID-19 患者出院后的血栓形成和出血。
Blood. 2020 Sep 10;136(11):1342-1346. doi: 10.1182/blood.2020007938.
6
Postdischarge venous thromboembolism following hospital admission with COVID-19.COVID-19 住院后出院后的静脉血栓栓塞症。
Blood. 2020 Sep 10;136(11):1347-1350. doi: 10.1182/blood.2020008086.
7
Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation.因房颤继发卒中预防而开始口服抗凝剂治疗后发生的致命性颅内出血。
Eur J Neurol. 2020 Aug;27(8):1612-1617. doi: 10.1111/ene.14280. Epub 2020 May 17.
8
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞：对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
9
Contemporary Meta-Analysis of Extended Direct-Acting Oral Anticoagulant Thromboprophylaxis to Prevent Venous Thromboembolism.当代直接作用口服抗凝药血栓预防的荟萃分析。
Am J Med. 2020 Sep;133(9):1074-1081.e8. doi: 10.1016/j.amjmed.2020.01.037. Epub 2020 Mar 6.
10
Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial.试验方案：一项针对新诊断免疫性血小板减少症一线治疗途径的多中心随机试验：标准类固醇治疗与类固醇联合霉酚酸酯治疗。FLIGHT试验。
BMJ Open. 2018 Oct 18;8(10):e024427. doi: 10.1136/bmjopen-2018-024427.
Zotero 插件